Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- The Microbiome: Looking at Microbes as More Than Pathogens
-
- 8 Recent FDA Updates in Gastroenterology, Hepatology
- Caroli’s Disease: Education About a Rare Inherited Disorder Mustafa A. Tiewala, MD; Frank G. Gress, MD
- FDA Approves Amjevita, Biosimilar to Humira
- FDA Approves Stelara for Crohn’s Disease
- FDA Approves Swallowable Intragastric Balloon for Obesity
- FDA Clears Phase 2 Trial of Drug Candidate for Ileus, Adhesions
- FDA Clears Single-use Colonoscopy Scope
- The Microbiome: Realizing its Greater Impact
-
- Loss of Response in the Treatment of Crohn’s Disease: A Case Study
- Fungus Linked to Dysbiosis in Crohn’s Disease
- Women at Greater Risk for Developing ALD, Liver Injury vs. Men
- Healio Gastroenterology 200 kicks off ACG 2016
- Emend Improves Gastroparesis Symptoms, Fails to Reach Endpoint
- Coffee Protects Against, Genetics Increase Risk for Alcoholic Hepatitis in Drinkers
- Remicade Prevents Serious Infection, Longer Hospitalization in UC Patients vs. Humira
- Remimazolam Safe, Effective for Outpatient Colonoscopy Sedation
-
- Xeljanz Induces Remission, Early Response Predicts Efficacy in UC
- ASGS Endorses Cellvizio for GERD, Barrett’s Esophagus